Skip to content

    Cellectar Biosciences (CLRB) stock price & financials

    View CLRB earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance47.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$13.33M
    -$12.74M
    -$6.40M
    -$6.04M
    -$4.85M
    +63.6%
    -$5.69M
    +55.3%
    -$5.79M
    +9.5%
    -$7.20M
    -19.2%
    Strengthening
    Net Profit
    -$14.66M
    -$2.36M
    -$6.60M
    -$5.45M
    -$4.44M
    +69.7%
    -$5.30M
    -124.8%
    -$5.65M
    +14.4%
    -$6.93M
    -27.2%
    Weakening
    EPS
    $-11.18
    $-4.30
    $-3.39
    $-1.41
    +87.4%
    $-1.33
    +69.1%
    $-0.57
    +83.2%
    Strengthening
    Other Income
    -$1.34M
    $10.46M
    -$203.0K
    $589.6K
    $406.8K
    $395.4K
    -96.2%
    $140.0K
    $265.4K
    -55.0%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    5.2%
    0.8%
    2.3%
    1.9%
    1.6%
    -69.7%
    1.9%
    +124.8%
    2.0%
    -14.4%
    2.5%
    +27.2%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$13.26M$10.61M$57.17M$35.70M$19.87M$9.56M$23.29M$13.20M$33.99M
    Short-Term Investments
    Total Current Assets$13.95M$11.39M$57.94M$36.57M$20.53M$10.45M$24.25M$14.04M$34.88M
    Net PP&E$543.3K$783.9K$638.3K$549.1K$979.0K$1.59M$1.19M$910.1K$1.74M
    Goodwill$0$0
    Intangibles
    Total Assets$15.05M$12.25M$58.66M$37.20M$21.59M$12.08M$25.47M$14.98M$36.64M
    LiabilitiesTotal Current Liabilities$1.62M$2.77M$3.56M$3.99M$11.50M$25.36M$9.39M$4.75M$5.24M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$421.6K$301.7K$166.3K$553.0K$494.0K$409.6K$309.4K$1.53M
    Total Liabilities$1.79M$3.19M$3.86M$4.16M$12.05M$25.85M$9.80M$5.06M$6.77M
    EquityCommon Stock & APIC$47$94$454$61$94$207$15$42$83
    Retained Earnings-$97.59M-$111.68M-$126.78M-$150.90M-$159.99M-$202.76M-$247.34M-$269.13M-$281.72M
    Total Equity$13.26M$9.06M$54.79M$29.06M$8.15M-$15.16M$14.29M$8.54M$29.87M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$11.44M-$11.69M-$13.93M-$22.57M-$25.22M-$32.38M-$47.58M-$23.12M-$19.47M
    Cash from Investing-$330.0K-$24.5K-$62.4K-$141.4K-$226.0K-$864.0K-$104.2K-$5.9K
    Cash from Financing$15.02M$9.02M$60.55M$1.25M$9.61M$22.94M$61.41M$13.03M
    SummaryCapital Expenditure-$385.0K-$24.5K-$62.4K-$141.4K-$226.0K-$864.0K-$104.2K-$5.9K
    Free Cash Flow-$11.83M-$11.72M-$14.00M-$22.71M-$25.45M-$33.24M-$47.69M-$23.12M
    FCF Margin

    Ratios